Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-17-005536
Filing Date
2017-05-26
Accepted
2017-05-26 17:21:29
Documents
19

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 1969705
2 GRAPHIC g14176g16t06.jpg GRAPHIC 138300
3 GRAPHIC g14176g20i27.jpg GRAPHIC 75822
4 GRAPHIC g14176g24i51.jpg GRAPHIC 100576
5 GRAPHIC g14176g29x09.jpg GRAPHIC 62826
6 GRAPHIC g14176g33x25.jpg GRAPHIC 44964
7 GRAPHIC g14176g46r76.jpg GRAPHIC 80850
8 GRAPHIC g14176g48g54.jpg GRAPHIC 95647
9 GRAPHIC g14176g49o72.jpg GRAPHIC 52285
10 GRAPHIC g14176g49x24.jpg GRAPHIC 87980
11 GRAPHIC g14176g56q31.jpg GRAPHIC 115886
12 GRAPHIC g14176g58k25.jpg GRAPHIC 78468
13 GRAPHIC g14176g75u22.jpg GRAPHIC 46833
14 GRAPHIC g14176g83g13.jpg GRAPHIC 29484
15 GRAPHIC g14176g83l86.jpg GRAPHIC 146472
16 GRAPHIC g14176g84k83.jpg GRAPHIC 189948
17 GRAPHIC g14176g85x25.jpg GRAPHIC 95011
18 GRAPHIC g14176g88j71.jpg GRAPHIC 112216
19 GRAPHIC g14176g98v10.jpg GRAPHIC 103344
  Complete submission text file 0000950123-17-005536.txt   4254976
Mailing Address 281 ALBANY STREET CAMBRIDGE MA 02139
Business Address 281 ALBANY STREET CAMBRIDGE MA 02139 617-995-0900
AILERON THERAPEUTICS INC (Filer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01150 | Film No.: 17874976
SIC: 2834 Pharmaceutical Preparations